Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endogenous Heparinoid Interference With Coagulation on Thromboelastogram as a Predictive Biomarker for Transfusion Related Acute Lung Injury (TRALI)

NCT01756690 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01756690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01756690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endogenous Heparinoid Interference With Coagulation on Thromboelastogram as a Predictive Biomarker for Transfusion Related Acute Lung Injury (TRALI)
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Terminated
Start date
October 31, 2011
Completion date
December 31, 2016
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease, gastrointestinal bleeding, transfusion-related acute lung injury